Clinical course of schizoaffective disorders

The Overlap of Affective and Schizophrenic Spectra

Volumn 9780521858588, Issue , 2006, Pages 145-155

  Reinares, Maria ^a   Vieta, Eduard ^a   Benabarre, Antoni ^a   Marneros, Andreas ^b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASES;

CLASSIFICATION SYSTEM; CLINICAL COURSE; EMPIRICAL FINDINGS; MODERN TIME; SIMPSON;

DIAGNOSIS;

EID: 73649116649     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511544040.009     Document Type: Chapter

References (53)

1. Angst, J. and Preisig, M. (1995). Course of a clinical cohort of unipolar, bipolar and schizoaffective patients. Results of a prospective study from 1959 to 1985. Schweizer Archiv für Neurologie und Psychiatrie, 146, 5–16.
2. Angst, J. and Marneros, A. (2001). Bipolarity from ancient to modern times: conception, birth and rebirth. Journal of Affective Disorders, 67, 3–19.
3. Atre-Vaidya, N. and Taylor, A. M. (1997). Differences in the prevalence of psychosensory features among schizophrenic, schizoaffective, and manic patients. Comprehensive Psychiatry, 38(2), 88–92.
4. Benabarre, A., Vieta, E., Colom, F. et al. (2001a). Bipolar disorder, schizoaffective disorder and schizophrenia: epidemiologic, clinical and prognostic differences. European Psychiatry, 16, 1–6.
5. Benabarre, A., Vieta, E., Reinares, M., Torrent, C. and Comes, M. (2001b). El curso clínico del trastorno esquizoafectivo. In Trastorno esquizoafectivo, ed. A. González-Pinto. Madrid: Aula Médica, p. 93–105.
6. Bottlender, R., Sato, T., Jäger, M. et al. (2002). The impact of duration of untreated psychosis and premorbid functioning on outcome of first inpatient treatment in schizophrenic and schizoaffective patients. European Archives of Psychiatry and Clinical Neuroscience, 252, 226–31.
7. Brockington, I. F., Kendell, R. E. and Wainwright, S. (1980). Depressed patients with schizophrenic or paranoid symptoms. Psychological Medicine, 10, 665–75.
8. Evans, J. D., Heaton, R. K., Paulsen, J. S. et al. (1999). Schizoaffective disorder: a form of schizophrenia or affective disorder?. The Journal of Clinical Psychiatry, 60, 974–82.
9. González-Pinto, A., Gutiérrez, M., Mosquera, F. et al. (1998). First episode in bipolar disorder: misdiagnosis and psychotic symptoms. Journal of Affective Disorders, 50, 41–4.
10. Grossman, L. S., Harrow, M., Fudala, J. and Meltzer, H. Y. (1984). The longitudinal course of schizoaffective disorders: a prospective follow-up study. The Journal of Nervous and Mental Disease, 172, 140–9.
11. Grossman, L. S., Harrow, M., Goldberg, J. F. and Fichtner, C. G. (1991). Outcome of schizoaffective disorder at two long-term follow-ups: comparisons with outcome of schizophrenia and affective disorders. American Journal of Psychiatry, 148, 1359–65.
12. Harrow, M. and Grossman, L. (1984). Outcome in schizoaffective disorders: a critical review and reevaluation of the literature. Schizophrenia Bulletin, 10, 87–108.
13. Harrow, M., Grossman, L. S., Herbener, E. S. and Davies, E. W. (2000). Ten-year outcome: patients with schizoaffective disorders, schizophrenia, affective disorders and moodincongruent psychotic symptoms. British Journal of Psychiatry, 177, 421–6.
14. Himmelhoch, J. M., Fuchs, C. Z., May, S. J., Symons, B. J. and Neil, J. F. (1981). When a schizoaffective diagnosis has meaning. The Journal of Nervous and Mental Disease, 169, 277–82.
15. Jäger, M., Bottlender, R., Strauss, A. and Möller, H. J. (2003). On the descriptive validity of ICD-10 schizophrenia: empirical analysis in the spectrum of non-affective functional psychoses. Psychopathology, 36,152–9.
16. Jäger, M., Bottlender, R., Strauss, A. and Möller, J. (2004). Fifteen-year follow-up of ICD-10 schizoaffective disorders compared with schizophrenia and affective disorders. Acta Psychiatrica Scandinavica, 109, 30–7.
17. Janicak, P. G., Keck, P. E., Davis, J. M. et al. (2001). A double-blind, randomized, prospective evaluation of the efficacy and safety of risperidone versus haloperidol in the treatment of schizoaffective disorder. Journal of Clinical Psychopharmacology, 21, 360–8.
18. Kahlbaum, K. (1863). Die Gruppirung der psychischen Krankheiten und die Eintheilung der Seelenstörungen. Danzing: Kafemann.
19. Kasanin, J. (1933). The acute schizoaffective psychoses. American Journal of Psychiatry, 13, 97–126.
20. Keck, P. E., Reeves, K. R. and Harrigan, E. P. (2001). Ziprasidone in the short-term treatment of patients with schizoaffective disorder: results from two double-blind, placebo-controlled, multicenter studies. Journal of Clinical Psychopharmacology, 21, 27–35.
21. Kendler, K. S., McGuire, M., Gurneberg, A. M. and Walsh, D. (1995). Examining the validity of DSM-III-R schizoaffective disorder and its putative subtypes in the Roscommon family study. American Journal of Psychiatry, 152, 755–64.
22. Levitt, J. J. and Tsuang, M. T. (1988). The heterogeneity of schizoaffective disorder: implications for treatment. American Journal of Psychiatry, 145, 926–36.
23. Maj, M., Pirozzi, R., Formicola, A. M., Bartoli, L. and Bucci, P. (2000). Reliability and validity of the DSM-IV diagnostic category of schizoaffective disorder: preliminary data. Journal of Affective Disorders, 57, 95–8.
24. Marneros, A. (2003a). The schizoaffective phenomenon: the state of the art. Acta Psychiatrica Scandinavica, 108(Suppl. 418): 29–33.
25. Marneros, A. (2003b). Schizoaffective disorder: clinical aspects, differential diagnosis, and treatment. Current Psychiatry Reports, 5, 202–5.
26. Marneros, A., Deister, A. and Rohde, A. (1990). Psychopathological and social status of patients with affective, schizophrenic and schizoaffective disorders after long-term course. Acta Psychiatrica Scandinavica, 82, 325–8.
27. Marneros, A., Deister, A. and Rohde, A. (1992). Comparisons of long-term outcome of schizophrenic, affective and schizoaffective disorders. British Journal of Psychiatry, 161(Suppl. 18), 44–51.
28. Marneros, A., Rohde, A. and Deister, A. (1993). Factors influencing the long-term outcome of schizoaffective disorders. Psychopathology, 26, 215–24.
29. Marneros, A., Rohde, A., Deister, A. (1998). Frequency and phenomenology of persisting alterations in affective, schizoaffective and schizophrenia disorders: a comparison. Psychopathology, 31, 23–8.
30. Marneros, A. and Angst, J. (2000). Bipolar Disorders. 100 Years after Manic Depressive Insanity. Dordrecht, Boston, London: Kluwer Academic Publishers.
31. Marneros, A., Röttig, S., Wenzel, A., Blöink, R. and Brieger, P. (2004). Affective and schizoaffective mixed states. European Archives of Psychiatry and Clinical Neuroscience, 254, 76–81.
32. Martínez-Arán, A., Vieta, E., Colom, F. et al. (2000). Cognitive dysfunctions in bipolar disorder: evidence of neuropsychological disturbances. Psychotherapy and Psychosomatics, 69, 2–18.
33. Maziade, M., Roy, M. A., Martínez, M. et al. (1995). Negative, psychotic, and disorganized dimensions in patients with familial schizophrenia or bipolar disorder: continuity and discontinuity between the major psychoses. American Journal of Psychiatry, 152, 1458–63.
34. McGlashan, T. H. and Williams, P. V. (1990). Predicting outcome in schizoaffective psychosis. The Journal of Nervous and Mental Disease, 178, 518–20.
35. Möller, H. J., Hohe-Schramm, M., Cording-Tommel, C. et al. (1989). The classification of functional psychoses and its implications for prognosis. British Journal of Psychiatry, 154, 467–72.
36. Möller, H., Bottlender, R., Wegner, U., Wittmann, J. and Strau, A. (2000). Long-term course of schizophrenic, affective and schizoaffective psychosis: focus on negative symptoms and their impact on global indicators of outcome. Acta Psychiatrica Scandinavica, 102(Suppl. 407), 54–7.
37. Möller, H., Bottlender, R., Gross, A. et al. (2002). The Kraepelinian dichotomy: preliminary results of a 15-year follow-up study on functional psychoses: focus on negative symptoms. Schizophrenia Research, 56, 87–94.
38. Pope, H. S., Lipinski, J. F., Cohen, B. M. and Axelrod, D. T. (1980). “Schizoaffective disorder”: an invalid diagnosis? A comparison of schizoaffective disorder, schizophrenia and affective disorder. American Journal of Psychiatry, 137, 921–7.
39. Procci, W. R. (1976). Schizoaffective psychosis: fact or fiction? Archives of General Psychiatry, 33, 1167–78.
40. Retterstol, N. (1991). Course and outcome in paranoid disorders. Psychopathology, 24, 277–86.
41. Salazar-Fraile, J., Tabarés-Seisdedos, R., Selva-Vera, G. et al. (2004). Recall and recognition confabulation in psychotic and bipolar disorders: evidence for two different types without unitary mechanisms. Comprehensive Psychiatry, 45, 281–8.
42. Samson, J. A., Simpson, J. C. and Tsuang, M. T. (1988). Outcome of schizoaffective disorders. Schizophrenia Bulletin, 14, 543–54.
43. Swainston-Harrison, T. and Perry, C. M. (2004). Aripiprazole: a review of its use in schizophrenia and schizoaffective disorder. Drugs, 64, 1715–36.
44. Tohen, M., Tsuang, M. T. and Goodwin, D. C. (1992). Prediction of outcome in mania by moodcongruent or mood-incongruent psychotic features. American Journal of Psychiatry, 149(11), 1580–4
45. Tran, P. V., Tollefson, G. D., Sanger, T. M. et al. (1999). Olanzapine versus haloperidol in the treatment of schizoaffective disorder. Acute and long-term therapy. British Journal of Psychiatry, 174, 15–22.
46. Tsuang, D. and Coryell, W. (1993). An 8-year follow-up of patients with DSM-III-R psychotic depression, schizoaffective disorder, and schizophrenia. American Journal of Psychiatry, 150, 1182–8.
47. Tsuang, M. T. and Fleming, J. A. (1986). Long-term outcome of schizophrenia and other psychoses. In Search for the Causes of Schizophrenia, p. 88–97.
48. Tsuang, M. T. and Simpson, J. C. (1984). Schizoaffective disorder: concept and reality. Schizophrenia Bulletin, 10, 14–25.
49. Tsuang, M. T., Stone, W. S. and Faraone, S. V. (2000). Schizoaffective and schizotypical disorders. In Gelder, M. G., López-Ibor, J. J. and Andreasen, N. (eds.) New Oxford Textbook of Psychiatry. Vol. 1. New York: Oxford University Press, pp. 636–42.
50. Vaillant, G. (1964). Prospective prediction of schizophrenic remission. Archives of General Psychiatry, 11, 509–18.
51. Vieta, E., Herraiz, M., Fernández, A. et al. (2001). Efficacy and safety of risperidone in the treatment of schizoaffective disorder: initial results from a large, multicenter surveillance study. Journal of Clinical Psychiatry, 62, 623–30.
52. Williams, P. V. and McGlashan, T. H. (1987). Schizoaffective psychosis, I: comparative long-term outcome. Archives of General Psychiatry, 44, 130–7.
53. Winokur, G., Monahan, P., Coryell, W. and Zimmerman, M. (1996). Schizophrenia and affective disorder – distinct entities or a continuum? An analysis based on a prospective 6-year follow up. Comprehensive Psychiatry, 37, 77–87.